Get started
Author

Charlotte Ahmadu

Observed names: Ahmadu, Charlotte, C Ahmadu, C. Ahmadu
ORCID: 0000-0001-6420-9071
Observed ORCID: 0000-0001-6420-9071
OpenAlex ID: A5031695309
SpaceOAR Hydrogel Spacer for Reducing Radiation Toxicity During Radiotherapy for Prostate Cancer. A Systematic Review
2021 · Nigel Armstrong, Amit Bahl, et al. · Urology · 73
Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis
2024 · Marie Westwood, Bram Ramaekers, et al. · Health Technology Assessment · 18
PDF
Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
2023 · Giovany Orozco Leal, Nigel Armstrong, et al. · PharmacoEconomics · 8
PDF
Filgotinib for Moderate to Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
2021 · Sabine E. Grimm, Ben Wijnen, et al. · PharmacoEconomics · 7
PDF
Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
2023 · Antoinette D. I. van Asselt, Nigel Armstrong, et al. · PharmacoEconomics · 5
PDF
Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
2023 · Mohamed N. M. T. Al Khayat, Nigel Armstrong, et al. · PharmacoEconomics · 4
PDF
Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
2021 · Sabine E. Grimm, Willem Witlox, et al. · PharmacoEconomics · 4
PDF
Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
2023 · Willem Witlox, Sabine Grimm, et al. · PharmacoEconomics · 3
PDF
Carer Health-Related Quality of Life: A Review of Modelling Considerations in National Institute for Health and Care Excellence Technology Appraisals (2000–2023)
2025 · Charlotte Ahmadu, Elise Evers, et al. · PharmacoEconomics - Open · 1
PDF
Correction to: Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
2022 · Sabine E. Grimm, Willem Witlox, et al. · PharmacoEconomics · 1
PDF
CO171 NMAs of Systemic Therapies for Advanced Biliary Tract Cancer: A Systematic Review and Critical Appraisal Using RoB NMA
2025 · Charlotte Ahmadu, Tiyi Morris, et al. · Value in Health
EE473 First-Line Immunotherapies for Advanced Biliary Tract Cancer: A Systematic Review of Economic Studies
2025 · Charlotte Ahmadu, Tiyi Morris, et al. · Value in Health
HTA5 A Cross-Sectional Analysis of Early Access Programs in NICE Health Technology Assessments
2025 · Charlotte Ahmadu, Oliver T. Darlington · Value in Health
HTA77 How to Best Model Caregiver Quality of Life in Health Technology Assessments? Lessons from NICE Submissions in Multiple Sclerosis
2025 · Charlotte Ahmadu, Oliver Darlington · Value in Health
HTA17 Are There Intersections in Evidence Requirements for Health Technology Assessment Agencies across North America, Europe and the Asia-Pacific?
2025 · Charlotte Ahmadu, Sarah L. Coyle, et al. · Value in Health
PCR210 Association Between Caregiver Quality of Life and the Care Provided to Adults With Severe Visual Impairments: A Systematic Literature Review
2025 · Andrew Mumford, Georgia Roberts, et al. · Value in Health
CO164 Novel Therapies for Neurofibromatosis Type 1-Associated Inoperable Plexiform Neurofibromas: A Systematic Literature Review
2025 · Andrew Mumford, Sarah L. Coyle, et al. · Value in Health
CO191 The Efficacy of Panitumumab Plus Chemotherapy As Initial Treatment for KRAS Wild-Type Unresectable, Metastatic Colorectal Cancer: A GRADE-Approach Systematic Review and Meta-Analysis
2025 · Charlotte Ahmadu, James Wantling, et al. · Value in Health
HTA97 Is the Assumption of Treatment Waning Applied Consistently Across Canada’s Drug Agency Reimbursement Reviews? Reviewing Pharmacoeconomic Assessments of Disease Modifying Therapies for the Treatment of Multiple Sclerosis
2025 · Charlotte Ahmadu, Tom Edmonds, et al. · Value in Health
HTA12 The Cost-Effectiveness of Immunotherapies for Advanced or Recurrent Endometrial Cancer: A Systematic Review
2024 · C Ahmadu, S Coyle, et al. · Value in Health
PDF
HTA13 Is Carer Burden a Given When Modelling Spinal Muscular Atrophy? Examining NICE Submissions
2024 · C Ahmadu, E Evers, et al. · Value in Health
PDF
HTA23 Caregiver Health-Related Quality of Life in National Institute for Health and Care (NICE) Appraisals: From Inception to 2023
2024 · C Ahmadu, O Darlington, et al. · Value in Health
PDF
HTA12 Investigating the Influence of Therapy-Related Factors on Reimbursement Success: A Multi-Country Analysis
2024 · R Piper, E Evers, et al. · Value in Health
PDF
RWD158 Estimates on Waste of Breast Cancer Related Chemotherapy Drugs in the NHS (ENGLAND)
2023 · T. Edmonds, E. Evers, et al. · Value in Health
PDF
Works count: 25
Citation count: 124
H-index: 5
I10-index: 2
Year
Topic
Type